DrMedHealth

What the DrMedHealth Intake Looks Like

We walked through the full DrMedHealth weight-loss assessment at drmedhealth.com. It’s a 22-screen intake with an explicit five-stage stepper (Start → Preliminary → Health → Details → Eligibility), upfront medication pricing across eight branded and compounded options, a government-ID upload requirement, an explicit Spanish-language service path, and a rare-in-this-catalog active drug or alcohol misuse screen. It is not the longest intake we’ve walked through — but it is one of only a few in our catalog that asks the substance-use question at all.

On the Serious Conditions screen in Stage 3, DrMedHealth lists “Active Drug or Alcohol Misuse” as one of the disqualifying-conditions checkboxes, directly alongside Medullary Thyroid Cancer, MEN-2 Syndrome, Serious Allergic Reaction to Semaglutide or Tirzepatide, and Active Cancer. Most public GLP-1 shopping funnels do not ask the substance-use question at all — they defer it to the clinician at a later step or skip it entirely. Listing it on the eligibility gate alongside the FDA black-box contraindications is a meaningful safety choice.

Stage 4 starts with a dedicated ID upload screen: “Please attach a copy of your photo ID — required for identity verification and prescription processing.” The uploader accepts JPG, PNG, and PDF with a file size limit, and the screen includes an “Identity Verification” note stating that “Your photo ID is required by law for prescription verification. It is securely encrypted and only accessible to licensed healthcare providers for verification purposes.” Shopping-funnel intakes in this catalog overwhelmingly skip the ID step — either deferring it to a follow-up email after checkout or not asking for it at all — so this is a real differentiator.

The Stage 2 medication preference screen is the most transparent pricing display we have seen in any intake walkthrough so far. All eight options are listed with monthly prices on the same screen: Compounded Semaglutide at $199, Compounded Tirzepatide at $299, Oral Compounded Semaglutide at $199, Oral Compounded Tirzepatide at $299, Ozempic at $899, Mounjaro at $999, and Wegovy at $999, plus a “Whatever my provider recommends” option. The screen is also one of the few anywhere in this catalog that offers oral compounded semaglutide and tirzepatide as tablets at the same price as the injection versions, for patients who aren’t comfortable with self-injection.

Stage 2 asks “What is your preferred language for communicating with our support team and medical doctors?” with three options — English, Spanish, and No preference. This is unusually explicit; most shopping-funnel intakes in our catalog assume English by default and do not offer a Spanish-language path on the public funnel at all. DrMedHealth also asks separately for consultation format preference (Email and text, Video, or Phone) on the preceding screen, so patients can match both the language and the channel before the clinical questions begin.

There is no mental-health screening of any kind — no PHQ-2, no PHQ-9, no suicidal-thoughts checkbox, no depression or anxiety questions. There is no pregnancy or breastfeeding check on the public funnel. There is no dedicated eating-disorder screen. There is no blood pressure or resting heart rate capture. There is no labs upload. Family history is only asked for MTC — not for heart disease, not for diabetes, and not for other endocrine conditions. For patients who know they have a complicated mental-health history or who are pregnant, planning pregnancy, or breastfeeding, these are questions that a clinician will have to raise after the intake is already complete.

Near the end of Stage 4, an acknowledgment screen informs patients that DrMedHealth has partnered with CareValidate, described as “a trusted leader with an expert network of physicians and pharmacies,” to operate the “CareGLP platform.” The fine print notes: “This secure, HIPAA-compliant system connects you to licensed physicians and prescription medications. Be on the lookout for emails or texts from DrMedHealth, CareGLP, or CareValidate regarding your care. Payments will be processed by CareValidate.” In other words, DrMedHealth is the front-end brand, but the actual clinical review, pharmacy network, and payment processing are handled by a third-party platform. That is useful context for anyone comparing brands — multiple consumer GLP-1 brands route through shared back-end platforms, and the customer service experience will reflect the back end as much as the front.

Opens drmedhealth.com in a new tab. We may earn a commission if you start treatment through this link, at no additional cost to you.